Shares of Imago BioSciences IMGO skyrocketed 104% on Nov 21 after the company announced that it has signed a definitive agreement with Merck MRK. Imago would be acquired by Merck for $36 per share in ...
Integrating Cloud-based Geoscientific Imagery Platform with Geology Data Management and Modeling Tools, Helping Solve Earth, Environment, and Energy Challenges EXTON, Pa.--(BUSINESS WIRE)--Bentley ...
Patients diagnosed with myeloproliferative neoplasm, a group of blood cancers in which the body overproduces red or white blood cells, don’t have great options. Treatment tends to be palliative, ...
Merck is shoring up its drug pipeline with the $1.35 billion buyout of Imago BioSciences, a biotech developing blood and bone marrow disorder therapies that could offer advantages over currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback